Enhanced Adherence of Sickle Erythrocytes to Thrombin-Treated Endothelial Cells Involves Interendothelial Cell Gap Formation
Open Access
- 1 November 1998
- journal article
- Published by American Society of Hematology in Blood
- Vol. 92 (9) , 3445-3454
- https://doi.org/10.1182/blood.v92.9.3445
Abstract
The adherence of sickle erythrocytes to vascular endothelium has the capacity to initiate vasoocclusion. The known effects of thrombin on endothelial cell function and the increased activity of thrombin in sickle cell disease led us to examine the effect of thrombin on the adhesivity of cultured endothelial cells for sickle erythrocytes. In particular, we studied whether the effect of thrombin on interendothelial cell gap formation (ICGF) was involved in endothelial cell adhesivity for sickle erythrocytes. Those endothelial cell monolayers stimulated by thrombin to maximal levels of static sickle erythrocyte adherence also underwent striking cell contraction and enlargement of interendothelial cell gaps. Adhesivity also increased when gaps were induced with antilaminin antibodies or EDTA. Maximally adhesogenic thrombin conditions failed to increase adhesivity when gap formation was prevented by pretreatment of the monolayers with 8-bromo-cyclic adenosine monophosphate (bromo-cAMP) or glutaraldehyde, agents that respectively inhibit actin-myosin–dependent cell contraction or cross-link adjacent cells in the monolayer. The influence of these two agents on EDTA-enhanced adhesivity was linked to their ability to prevent gap formation. Glutaraldehyde prevented both increased adherence and gap formation; bromo-cAMP prevented neither. Interendothelial cell gap formation may contribute to vasoocclusion by facilitating sickle erythrocyte adherence.© 1998 by The American Society of Hematology.Keywords
This publication has 56 references indexed in Scilit:
- Perspectives series: cell adhesion in vascular biology. Adhesive interactions of sickle erythrocytes with endothelium.Journal of Clinical Investigation, 1997
- Disturbance of plasma and platelet thrombospondin levels in sickle cell diseaseAmerican Journal of Hematology, 1996
- Molecular basis of sickle cell-endothelial cell interactionsCurrent Opinion in Hematology, 1996
- Low‐intensity oral anticoagulation in sickle‐cell disease reverses the prethrombotic state: promises for treatment?British Journal of Haematology, 1995
- Leukocyte-endothelial adhesion moleculesBlood, 1994
- Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion.The Journal of cell biology, 1992
- Laboratory profile of sickle cell disease: A cross-sectional analysisJournal of Clinical Epidemiology, 1992
- Regulation of Platelet-Activating Factor (PAF) Synthesis and PAF-Mediated Neutrophil Adhesion to Endothelial Cells Activated by ThrombinSeminars in Thrombosis and Hemostasis, 1992
- Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications.Proceedings of the National Academy of Sciences, 1989
- Sickle-Cell Anemia: Molecular and Cellular Bases of Therapeutic ApproachesNew England Journal of Medicine, 1978